UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) hit a new 52-week high during trading on Thursday following a better than expected earnings announcement. The stock traded as high as $461.62 and last traded at $452.6820, with a volume of 2997048 shares changing hands. The stock had previously closed at $418.52.
The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.87 by $1.51. The business had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm’s quarterly revenue was up .4% compared to the same quarter last year. During the same period last year, the firm posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were given a $2.32 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.1%. UnitedHealth Group’s dividend payout ratio is presently 70.09%.
Key Headlines Impacting UnitedHealth Group
- Positive Sentiment: UnitedHealth beat Q2 expectations, reporting EPS of $6.38 versus estimates around $4.87-$4.94 and revenue of $112.03 billion, topping forecasts. UnitedHealth Group Reports Second Quarter 2026 Results
- Positive Sentiment: The company raised its 2026 adjusted EPS guidance to $19.50-$20.00, above prior outlook and Wall Street expectations, signaling improving profitability. UnitedHealth Group Reports Second Quarter 2026 Results
- Positive Sentiment: UnitedHealth said medical costs are easing and Optum operating income is improving, which supports the turnaround thesis and helps explain the stock’s premarket strength. Reuters article on higher forecast
- Positive Sentiment: The company also said it remains on track to repurchase at least $5 billion of stock in 2026, adding another shareholder-return tailwind. RTT News article on strong profit and outlook
- Neutral Sentiment: Broader market headlines noted weakness in the AI trade and mixed futures, but UNH’s move appears driven mainly by its own earnings beat and guidance increase rather than sector-wide momentum. Nasdaq Futures Fall as AI Trade Loses Steam
Wall Street Analyst Weigh In
UNH has been the subject of several research analyst reports. Oppenheimer lifted their price objective on UnitedHealth Group from $385.00 to $405.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Weiss Ratings upgraded shares of UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 10th. Zacks Research upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Monday. Morgan Stanley upped their target price on shares of UnitedHealth Group from $453.00 to $468.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 30th. Finally, TD Cowen boosted their price target on shares of UnitedHealth Group from $337.00 to $430.00 and gave the stock a “hold” rating in a report on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $429.50.
View Our Latest Analysis on UNH
Insider Buying and Selling at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares in the company, valued at approximately $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.28% of the company’s stock.
Institutional Investors Weigh In On UnitedHealth Group
A number of hedge funds have recently modified their holdings of the stock. Walker Asset Management LLC purchased a new position in UnitedHealth Group in the second quarter valued at approximately $229,000. Ballast Inc. raised its stake in shares of UnitedHealth Group by 11.4% in the second quarter. Ballast Inc. now owns 17,484 shares of the healthcare conglomerate’s stock valued at $7,267,000 after buying an additional 1,791 shares during the period. Regent Peak Wealth Advisors LLC grew its stake in shares of UnitedHealth Group by 21.3% during the 2nd quarter. Regent Peak Wealth Advisors LLC now owns 1,620 shares of the healthcare conglomerate’s stock worth $673,000 after acquiring an additional 285 shares during the period. Annex Advisory Services LLC raised its stake in UnitedHealth Group by 159.6% in the 2nd quarter. Annex Advisory Services LLC now owns 68,577 shares of the healthcare conglomerate’s stock valued at $28,503,000 after acquiring an additional 42,157 shares during the period. Finally, Whitener Capital Management Inc. boosted its position in UnitedHealth Group by 43.0% during the second quarter. Whitener Capital Management Inc. now owns 3,893 shares of the healthcare conglomerate’s stock worth $1,618,000 after purchasing an additional 1,171 shares during the period. Institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Trading Up 5.8%
The firm’s 50-day moving average price is $402.80 and its 200-day moving average price is $341.04. The company has a market cap of $401.94 billion, a P/E ratio of 33.43, a price-to-earnings-growth ratio of 1.70 and a beta of 0.62. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69.
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Further Reading
- Five stocks we like better than UnitedHealth Group
- AI’s Power Crunch Fuels a Pivot for These 2 Oilfield Stocks
- Why Conagra’s Dividend Cut Could Be the Best Thing for Investors
- Japan’s Crypto Overhaul Could Open the Door to a Wave of Institutional Money
- Cintas Keeps Beating Expectations—And the Story Isn’t Over
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
